(INTT) inTest - Overview
Sector: TechnologyIndustry: Semiconductor Equipment & Materials | Exchange NYSE MKT (USA) | Currency USD | Market Cap: 189m | Total Return 90.1% in 12m
Stock: Test Equipment, Thermal Systems, Induction Heating
Total Rating 49
Risk 83
Buy Signal 0.13
| Risk 5d forecast | |
|---|---|
| Volatility | 57.4% |
| Relative Tail Risk | -1.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.36 |
| Alpha | 70.45 |
| Character TTM | |
|---|---|
| Beta | 1.415 |
| Beta Downside | 2.831 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.82% |
| CAGR/Max DD | -0.14 |
EPS (Earnings per Share)
Revenue
Description: INTT inTest March 16, 2026
inTEST Corporation provides test and process technology solutions across multiple sectors. These include automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets. The company operates globally.
The Electronic Test segment supplies equipment for semiconductor testing. This includes manipulators, docking hardware, and tester interfaces. The semiconductor industry relies on such equipment for quality control during chip manufacturing. This segment also offers robotic-based test systems and automated test services.
The Environmental Technologies segment focuses on temperature management solutions. Products include ThermoStream systems, thermal chambers, and ultra-cold storage units. Temperature control is critical for testing electronic components and for life science applications like biomedical storage.
The Process Technologies segment provides induction heating systems and digital imaging solutions. Induction heating is used in various industrial processes for efficient and precise heating of materials.
inTEST markets its products to semiconductor manufacturers, foundries, test and assembly providers, and original equipment manufacturers. To understand INTTs market position, further research into its competitive landscape and financial performance is recommended.
Headlines to watch out for
- Semiconductor capital expenditure cycles impact Electronic Test segment revenue
- Automotive and industrial sector demand drives Process Technologies growth
- Life sciences and defense spending boosts Environmental Technologies sales
- Global supply chain disruptions increase manufacturing costs
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -2.53m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.12 > 1.0 |
| NWC/Revenue: 37.67% < 20% (prev 35.86%; Δ 1.82% < -1%) |
| CFO/TA 0.05 > 3% & CFO 7.32m > Net Income -2.53m |
| Net Debt (1.35m) to EBITDA (3.08m): 0.44 < 3 |
| Current Ratio: 2.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (12.3m) vs 12m ago 0.50% < -2% |
| Gross Margin: 42.98% > 18% (prev 0.42%; Δ 4.26k% > 0.5%) |
| Asset Turnover: 74.98% > 50% (prev 85.82%; Δ -10.83% > 0%) |
| Interest Coverage Ratio: -6.16 > 6 (EBITDA TTM 3.08m / Interest Expense TTM 450k) |
Altman Z'' 3.65
| A: 0.28 (Total Current Assets 78.6m - Total Current Liabilities 35.8m) / Total Assets 151.3m |
| B: 0.28 (Retained Earnings 42.6m / Total Assets 151.3m) |
| C: -0.02 (EBIT TTM -2.77m / Avg Total Assets 151.8m) |
| D: 0.95 (Book Value of Equity 45.1m / Total Liabilities 47.7m) |
| Altman-Z'' Score: 3.65 = AA |
Beneish M -3.18
| DSRI: 1.01 (Receivables 25.9m/29.5m, Revenue 113.8m/130.7m) |
| GMI: 0.99 (GM 42.98% / 42.41%) |
| AQI: 1.02 (AQ_t 0.39 / AQ_t-1 0.38) |
| SGI: 0.87 (Revenue 113.8m / 130.7m) |
| TATA: -0.07 (NI -2.53m - CFO 7.32m) / TA 151.3m) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of INTT shares?
As of March 27, 2026, the stock is trading at USD 14.26 with a total of 126,551 shares traded.
Over the past week, the price has changed by +1.06%, over one month by +42.74%, over three months by +89.63% and over the past year by +90.13%.
Over the past week, the price has changed by +1.06%, over one month by +42.74%, over three months by +89.63% and over the past year by +90.13%.
Is INTT a buy, sell or hold?
inTest has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy INTT.
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the INTT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.7 | 23.9% |
| Analysts Target Price | 17.7 | 23.9% |
INTT Fundamental Data Overview March 27, 2026
P/E Forward = 21.5983
P/S = 1.6577
P/B = 1.6918
Revenue TTM = 113.8m USD
EBIT TTM = -2.77m USD
EBITDA TTM = 3.08m USD
Long Term Debt = 1.41m USD (from longTermDebt, last quarter)
Short Term Debt = 8.16m USD (from shortTermDebt, last quarter)
Debt = 15.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.35m USD (from netDebt column, last quarter)
Enterprise Value = 190.0m USD (188.7m + Debt 15.6m - CCE 14.2m)
Interest Coverage Ratio = -6.16 (Ebit TTM -2.77m / Interest Expense TTM 450k)
EV/FCF = 33.44x (Enterprise Value 190.0m / FCF TTM 5.68m)
FCF Yield = 2.99% (FCF TTM 5.68m / Enterprise Value 190.0m)
FCF Margin = 4.99% (FCF TTM 5.68m / Revenue TTM 113.8m)
Net Margin = -2.22% (Net Income TTM -2.53m / Revenue TTM 113.8m)
Gross Margin = 42.98% ((Revenue TTM 113.8m - Cost of Revenue TTM 64.9m) / Revenue TTM)
Gross Margin QoQ = 45.39% (prev 41.90%)
Tobins Q-Ratio = 1.26 (Enterprise Value 190.0m / Total Assets 151.3m)
Interest Expense / Debt = 0.54% (Interest Expense 84.0k / Debt 15.6m)
Taxrate = 9.73% (134k / 1.38m)
NOPAT = -2.50m (EBIT -2.77m * (1 - 9.73%)) [loss with tax shield]
Current Ratio = 2.20 (Total Current Assets 78.6m / Total Current Liabilities 35.8m)
Debt / Equity = 0.15 (Debt 15.6m / totalStockholderEquity, last quarter 103.6m)
Debt / EBITDA = 0.44 (Net Debt 1.35m / EBITDA 3.08m)
Debt / FCF = 0.24 (Net Debt 1.35m / FCF TTM 5.68m)
Total Stockholder Equity = 101.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.66% (Net Income -2.53m / Total Assets 151.3m)
RoE = -2.48% (Net Income TTM -2.53m / Total Stockholder Equity 101.9m)
RoCE = -2.68% (EBIT -2.77m / Capital Employed (Equity 101.9m + L.T.Debt 1.41m))
RoIC = -2.25% (negative operating profit) (NOPAT -2.50m / Invested Capital 111.4m)
WACC = 10.16% (E(188.7m)/V(204.2m) * Re(10.96%) + D(15.6m)/V(204.2m) * Rd(0.54%) * (1-Tc(0.10)))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.64%
[DCF] Terminal Value 62.94% ; FCFF base≈4.41m ; Y1≈3.06m ; Y5≈1.56m
[DCF] Fair Price = 1.65 (EV 21.9m - Net Debt 1.35m = Equity 20.6m / Shares 12.5m; r=10.16% [WACC]; 5y FCF grow -35.98% → 3.0% )
EPS Correlation: -63.65 | EPS CAGR: 7.97% | SUE: 0.36 | # QB: 0
Revenue Correlation: 7.37 | Revenue CAGR: 8.61% | SUE: 1.02 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.10 | Chg7d=+0.007 | Chg30d=+0.023 | Revisions Net=+2 | Analysts=3
EPS current Year (2026-12-31): EPS=0.42 | Chg7d=+0.007 | Chg30d=+0.077 | Revisions Net=+2 | Growth EPS=+594.4% | Growth Revenue=+13.6%
EPS next Year (2027-12-31): EPS=0.62 | Chg7d=+0.133 | Chg30d=+0.123 | Revisions Net=+1 | Growth EPS=+49.6% | Growth Revenue=+9.1%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
P/S = 1.6577
P/B = 1.6918
Revenue TTM = 113.8m USD
EBIT TTM = -2.77m USD
EBITDA TTM = 3.08m USD
Long Term Debt = 1.41m USD (from longTermDebt, last quarter)
Short Term Debt = 8.16m USD (from shortTermDebt, last quarter)
Debt = 15.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.35m USD (from netDebt column, last quarter)
Enterprise Value = 190.0m USD (188.7m + Debt 15.6m - CCE 14.2m)
Interest Coverage Ratio = -6.16 (Ebit TTM -2.77m / Interest Expense TTM 450k)
EV/FCF = 33.44x (Enterprise Value 190.0m / FCF TTM 5.68m)
FCF Yield = 2.99% (FCF TTM 5.68m / Enterprise Value 190.0m)
FCF Margin = 4.99% (FCF TTM 5.68m / Revenue TTM 113.8m)
Net Margin = -2.22% (Net Income TTM -2.53m / Revenue TTM 113.8m)
Gross Margin = 42.98% ((Revenue TTM 113.8m - Cost of Revenue TTM 64.9m) / Revenue TTM)
Gross Margin QoQ = 45.39% (prev 41.90%)
Tobins Q-Ratio = 1.26 (Enterprise Value 190.0m / Total Assets 151.3m)
Interest Expense / Debt = 0.54% (Interest Expense 84.0k / Debt 15.6m)
Taxrate = 9.73% (134k / 1.38m)
NOPAT = -2.50m (EBIT -2.77m * (1 - 9.73%)) [loss with tax shield]
Current Ratio = 2.20 (Total Current Assets 78.6m / Total Current Liabilities 35.8m)
Debt / Equity = 0.15 (Debt 15.6m / totalStockholderEquity, last quarter 103.6m)
Debt / EBITDA = 0.44 (Net Debt 1.35m / EBITDA 3.08m)
Debt / FCF = 0.24 (Net Debt 1.35m / FCF TTM 5.68m)
Total Stockholder Equity = 101.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.66% (Net Income -2.53m / Total Assets 151.3m)
RoE = -2.48% (Net Income TTM -2.53m / Total Stockholder Equity 101.9m)
RoCE = -2.68% (EBIT -2.77m / Capital Employed (Equity 101.9m + L.T.Debt 1.41m))
RoIC = -2.25% (negative operating profit) (NOPAT -2.50m / Invested Capital 111.4m)
WACC = 10.16% (E(188.7m)/V(204.2m) * Re(10.96%) + D(15.6m)/V(204.2m) * Rd(0.54%) * (1-Tc(0.10)))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.64%
[DCF] Terminal Value 62.94% ; FCFF base≈4.41m ; Y1≈3.06m ; Y5≈1.56m
[DCF] Fair Price = 1.65 (EV 21.9m - Net Debt 1.35m = Equity 20.6m / Shares 12.5m; r=10.16% [WACC]; 5y FCF grow -35.98% → 3.0% )
EPS Correlation: -63.65 | EPS CAGR: 7.97% | SUE: 0.36 | # QB: 0
Revenue Correlation: 7.37 | Revenue CAGR: 8.61% | SUE: 1.02 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.10 | Chg7d=+0.007 | Chg30d=+0.023 | Revisions Net=+2 | Analysts=3
EPS current Year (2026-12-31): EPS=0.42 | Chg7d=+0.007 | Chg30d=+0.077 | Revisions Net=+2 | Growth EPS=+594.4% | Growth Revenue=+13.6%
EPS next Year (2027-12-31): EPS=0.62 | Chg7d=+0.133 | Chg30d=+0.123 | Revisions Net=+1 | Growth EPS=+49.6% | Growth Revenue=+9.1%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)